Trial intelligence / Profile preview

Pioglitazone for bipolar mixed or depressive episode

IRCT201211211556N46Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pioglitazone in bipolar disorder (BD), sponsored by Tehran University of Medical Sciences. Started Dec 2012; status: completed.

02

Drugs

pioglitazone
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on IRCT201211211556N46.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201211211556N46.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call